Guido Middeler

562 total citations
5 papers, 417 citations indexed

About

Guido Middeler is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Guido Middeler has authored 5 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Genetics and 2 papers in Oncology. Recurrent topics in Guido Middeler's work include Virus-based gene therapy research (3 papers), CRISPR and Genetic Engineering (3 papers) and Angiogenesis and VEGF in Cancer (1 paper). Guido Middeler is often cited by papers focused on Virus-based gene therapy research (3 papers), CRISPR and Genetic Engineering (3 papers) and Angiogenesis and VEGF in Cancer (1 paper). Guido Middeler collaborates with scholars based in Germany. Guido Middeler's co-authors include Hugo A. Katus, Wolfgang-M. Franz, Oliver J. Müller, Bernd K. Fleischmann, Peter Schlenke, J. Hescheler, G. J. Ji, Elmar Endl, A. M. Wobus and Sebastian Frese and has published in prestigious journals such as Oncogene, The FASEB Journal and Gene Therapy.

In The Last Decade

Guido Middeler

5 papers receiving 396 citations

Peers

Guido Middeler
Comparison fields: 5 of 53
  • Molecular Biology 329
  • Surgery 161
  • Genetics 91
  • Cardiology and Cardiovascular Medicine 86
  • Oncology 54
Replace Robert E. Welikson with:
Robert E. Welikson United States
Takeshi Hatani Japan
Sapana N. Shah United States
T G Sherratt United Kingdom
Marybeth Camboni United States
Shilpita Sarcar Belgium
Jim Swildens Netherlands
Moon Jong Noh South Korea
Laëtitia Guével France
Junko Shimomura Japan
Robert E. Welikson United States View profile →
Citations per field, relative to Guido Middeler
Guido Middeler · 1×
Citations per year, relative to Guido Middeler
Guido Middeler · 1×

Countries citing papers authored by Guido Middeler

Since Specialization
Citations

This map shows the geographic impact of Guido Middeler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Middeler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Middeler more than expected).

Fields of papers citing papers by Guido Middeler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Middeler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Middeler. The network helps show where Guido Middeler may publish in the future.

Co-authorship network of co-authors of Guido Middeler

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Middeler. A scholar is included among the top collaborators of Guido Middeler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Middeler. Guido Middeler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
# Work Indexed citations
1 14
2 1
3 117
4 209
5 76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026